Skip to content

Stem Cell therapy on human Fecal incontinence

Results assessment of autologous implantation of human Adipose drived stem cells in external anal sphincter and fecal incontinence: a phase II clinical trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160201026316N3
Enrollment
30
Registered
2018-07-26
Start date
2018-06-30
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Faecal incontinence. Faecal incontinence

Interventions

Intervention 1: Intervention group: External anal sphincter muscle repair and 20 milions hADSCs ( suspended in 3 ml Phosphate Buffer Solution) implantation in the external anal sphincter is done. Int

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to No maximum

Inclusion criteria

Inclusion criteria: Age?>25 years Wexner score?=?8 Confirmation of external anal sphincter defect with endorectal ultrasonography Patient consent for inclusion

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding Participating in other trials within the past 30 days History of artificial sphincter Vaginal delivery within the past 6 months Presence of chronic diseases Autoimmune disease

Design outcomes

Primary

MeasureTime frame
Wexner Score. Timepoint: 2 months after intervention. Method of measurement: Wexner Schedule (Standard schedule for assessment of fecal incontinence according to patient history).;Rate of wound closure. Timepoint: Immediately after surgery to wound closure. Method of measurement: Experienced surgeon view.

Secondary

MeasureTime frame
External anal sphincter action potential record in the defect site. Timepoint: Two months after intervention. Method of measurement: Electromyography.;External anal sphincter morphology. Timepoint: Two months after intervention. Method of measurement: Endorectal Sonography.;Amount of muscle in the external anal sphincter defect site. Timepoint: Two months after intervention. Method of measurement: Image J software.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArash Sarveazad

Iran University of Medical Sciences

Arashsarveazad@gmail.com+98 21 6655 4790

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026